|
|
Pharmaceutical and Biomedical Research، جلد ۹، شماره ۴، صفحات ۲۵۹-۲۶۶
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
Diagnosis and Critique of Drugs Used in Treating Coronavirus Disease in 2019 in Nigeria: A Review |
|
| چکیده انگلیسی مقاله |
Background and Objectives: Drugs used in treating patients who contracted the coronavirus disease of 2019 (COVID-19) include chloroquine or hydroxychloroquine (CQ, HCQ), antiviral, steroid, and antibiotic. Treatment outcomes were characterized by positive and adverse reactions as therapeutic options were based on clinical trials coupled with diagnostic constraints. This study assesses the diagnostic processes and critically examines the drugs used in the clinical settings to treat COVID-19 in Nigeria.
Methods: The search was conducted on various databases with a focus on diagnoses and drugs used to treat COVID-19. Articles that did not meet selection criteria were excluded and the data collected from sampled articles were collated, analyzed, and evaluated.
Results: The finding showed a lack of sufficient evidence-based data to support the use of CQ/HCQ, remdesivir, lopinavir/ritonavir, and antibiotics, such as azithromycin as treatment options for COVID-19, even though patients responded partly to the drugs probably due to their action mechanisms.
Conclusion: There is a lack of evidence-based scientific data to guide the definitive treatment of COVID-19 patients during the pandemic. Drugs used in the emergency were based on clinical trials. The efficacy of the drugs depends partly on the innate capability of the immune system of an affected individual. |
|
| کلیدواژه‌های انگلیسی مقاله |
Anti-bacterial agents, Antiviral agents, COVID-19 diagnostic testing, COVID-19 drug treatment, Hydroxychloroquine, Nigeria |
|
| نویسندگان مقاله |
| Tajudeen Olusegun Rasheed
Department of Health, Safety & Environment Studies, Training & Research Institute, Economic and Financial Crimes Commission Academy, Karu, Nigeria
| Wael Mohamed Noaman Higazy
Department of Pharmacy, EISAI Pharmaceuticals, Nutley, United States of America.
| Bilawu Yisa Abiodun
Department of Nursing, Lagos State College of Nursing, Igando, Nigeria.
|
|
| نشانی اینترنتی |
http://pbr.mazums.ac.ir/browse.php?a_code=A-10-1201-1&slc_lang=en&sid=1 |
| فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
کارآزمایی بالینی دارو |
| نوع مقاله منتشر شده |
مروری |
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|